Back to results
US 2011/0237677 A1Published application
Inhibitors
AssigneeThe University of Nottingham
InventorsJoelle Alcock, Joanne Lymn, Raheela Khan
Life of this patent
Estimating the term…
Abstract
The invention relates to inhibitors of tissue transglutaminase II activity and their use as a tocolytic agent.
Claims18
-36. (canceled)
A method of treating or preventing a disorder originating in uterine contractions in a subject, said method comprising administering to the subject a therapeutically effective amount of an inhibitor of transglutaminase II (tTgII).
A pharmaceutical formulation comprising an inhibitor of transglutaminase II (tTgII) in an amount effective to inhibit or counter the onset of uterine contractions, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.